{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:48:12Z","timestamp":1787615292067,"version":"build-2736575974"},"reference-count":110,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jfo.2015.11.008","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T19:34:24Z","timestamp":1458243264000},"page":"292-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["La ciclosporine\u00a0topique en ophtalmologie\u00a0: pharmacologie et indications th\u00e9rapeutiques"],"prefix":"10.1016","volume":"39","author":[{"given":"O.","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Borderie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bouheraoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2015.11.008_bib0555","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2015.11.008_bib0560","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(79)92082-8","article-title":"Prolonged survival of corneal allografts in rabbits treated with cyclosporin A","volume":"2","author":"Coster","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2015.11.008_bib0565","first-page":"173","article-title":"Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection","volume":"45","author":"Hunter","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0570","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0575","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0041-1345(98)00577-6","article-title":"Calcineurin and the biological effect of cyclosporine and tacrolimus","volume":"30","author":"Halloran","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfo.2015.11.008_bib0580","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","article-title":"Cyclophilin D as a drug target","volume":"10","author":"Waldmeier","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jfo.2015.11.008_bib0585","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0590","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.284.5412.339","article-title":"Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD","volume":"284","author":"Wang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jfo.2015.11.008_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399400001769","article-title":"Molecular targets for existing and novel immunosuppressive drugs","volume":"2","author":"Stepkowski","year":"2000","journal-title":"Expert Rev Mol Med"},{"issue":"Suppl. 67","key":"10.1016\/j.jfo.2015.11.008_bib0600","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.0366-077X.2004.05949.x","article-title":"Ciclosporin in psoriasis clinical practice: an international consensus statement","volume":"150","author":"Griffiths","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0605","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1582-4934.2004.tb00321.x","article-title":"Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease","volume":"8","author":"Kountouras","year":"2004","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jfo.2015.11.008_bib0610","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10384-004-0098-3","article-title":"Effect of immunosuppression on survival of allograft limbal stem cells","volume":"48","author":"Chen","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0615","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021227019915","article-title":"Long-term therapy with low dose cyclosporin A in ocular Beh\u00e7et's disease","volume":"105","author":"Ozdal","year":"2002","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0620","first-page":"637","article-title":"Immunosuppression in corneal transplantation","volume":"26","author":"Scheer","year":"2003","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0625","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICO.0000000000000291","article-title":"Topical cyclosporine in corneal transplantation","volume":"34","author":"Ziaei","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0630","first-page":"1362","article-title":"Ocular penetration of cyclosporin A. The rabbit eye","volume":"31","author":"Ben Ezra","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0635","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","article-title":"A large prospective observational study of novel cyclosporine 0,1\u00a0% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis","volume":"25","author":"Ebihara","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2015.11.008_bib0640","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jfo.2015.02.008","article-title":"Cyclosporine eye drops: a 4-year retrospective study (2009\u20132013)","volume":"38","author":"Kauss Hornecker","year":"2015","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0645","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0650","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0655","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase\u00a03\u00a0Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0660","first-page":"4133","article-title":"Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone","volume":"41","author":"Bourcier","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0665","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren's syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2015.11.008_bib0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ico.0000141486.56931.9b","article-title":"The tear film complex: pathogenesis and emerging therapies for dry eyes","volume":"24","author":"Smith","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0675","first-page":"2283","article-title":"Pro- and anti-inflammatory forms of interleukin-1\u00a0in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0680","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","article-title":"Interleukin-6\u00a0levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion","volume":"19","author":"Turner","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0685","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0690","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00003226-200111000-00019","article-title":"Quantification of MUC5AC protein in human tears","volume":"20","author":"Zhao","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0695","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3928\/1081597X-20080401-04","article-title":"Cyclosporine 0.05\u00a0% ophthalmic preparation to aid recovery from loss of corneal sensitivity after LASIK","volume":"24","author":"Peyman","year":"2008","journal-title":"J Refract Surg"},{"key":"10.1016\/j.jfo.2015.11.008_bib0700","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ICO.0b013e3181acf68d","article-title":"Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy","volume":"29","author":"Toker","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0705","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1167\/iovs.11-8445","article-title":"Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves","volume":"53","author":"Namavari","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0710","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0006-8993(92)90364-F","article-title":"Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines","volume":"569","author":"Yoshida","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.jfo.2015.11.008_bib0715","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/S0021-9258(18)53813-8","article-title":"Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells","volume":"268","author":"Hattori","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfo.2015.11.008_bib0720","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ophtha.2005.09.033","article-title":"Topical 0.1\u00a0% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients","volume":"113","author":"Lee","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0725","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.94.5.2019","article-title":"Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models","volume":"94","author":"Steiner","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jfo.2015.11.008_bib0730","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm0497-421","article-title":"Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A","volume":"3","author":"Steiner","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.jfo.2015.11.008_bib0735","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00007890-199809270-00012","article-title":"Successful nerve regeneration and persistence of donor cells after a limited course of immunosuppression in rat peripheral nerve allografts","volume":"66","author":"Katsube","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jfo.2015.11.008_bib0740","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.exer.2008.03.002","article-title":"Alterations in corneal sensitivity and nerve morphology in patients with primary Sj\u00f6gren's syndrome","volume":"86","author":"Tuisku","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2015.11.008_bib0745","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/ICO.0b013e31802e3b55","article-title":"In vivo confocal microscopic evaluation of langerhans cell density and distribution in the corneal epithelium of healthy volunteers and contact lens wearers","volume":"26","author":"Zhivov","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0750","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1167\/iovs.09-3629","article-title":"Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye","volume":"51","author":"Lin","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0755","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/cea.12264","article-title":"An essential role for dendritic cells in vernal keratoconjunctivitis: analysis by laser scanning confocal microscopy","volume":"44","author":"Liu","year":"2014","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0760","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop, (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jfo.2015.11.008_bib0765","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exer.2003.09.003","article-title":"The role of the lacrimal functional unit in the pathophysiology of dry eye","volume":"78","author":"Stern","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2015.11.008_bib0770","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0161-6420(99)90171-9","article-title":"Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sj\u00f6gren syndrome","volume":"106","author":"Marsh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0775","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidelines for management of dry eye associated with Sj\u00f6gren disease","volume":"13","author":"Foulks","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jfo.2015.11.008_bib0780","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","article-title":"Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sj\u00f6gren's syndrome","volume":"72","author":"G\u00fcnd\u00fcz","year":"1994","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0785","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00003226-199307000-00007","article-title":"Pilot trial of cyclosporine 1\u00a0% ophthalmic ointment in the treatment of keratoconjunctivitis sicca","volume":"12","author":"Laibovitz","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0790","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2\u00a0Study Group","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0795","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/ICO.0b013e318074e460","article-title":"Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye","volume":"26","author":"Roberts","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0800","first-page":"14","article-title":"Dry eye symptoms following cataract surgery","volume":"32","author":"Roberts","year":"2007","journal-title":"Insight"},{"key":"10.1016\/j.jfo.2015.11.008_bib0805","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","article-title":"Safety and efficacy of cyclosporine 0.05\u00a0% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis","volume":"32","author":"Salib","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2015.11.008_bib0810","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","article-title":"Anti-inflammatory therapy for dry eye","volume":"137","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0815","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ICO.0b013e31818c69ef","article-title":"Efficacy of combined 0.05\u00a0% cyclosporine and 1\u00a0% methylprednisolone treatment for chronic dry eye","volume":"31","author":"Byun","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0820","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"Sacchetti","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0825","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/ICL.0b013e3180676d44","article-title":"Efficacy of cyclosporine 0.05\u00a0% ophthalmic emulsion in contact lens wearers with dry eyes","volume":"34","author":"Willen","year":"2008","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2015.11.008_bib0830","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1442-9071.2009.02090.x","article-title":"Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye","volume":"37","author":"Guzey","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0835","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/eye.2009.246","article-title":"Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients","volume":"24","author":"Altiparmak","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2015.11.008_bib0840","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bjo.2008.150011","article-title":"A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome","volume":"94","author":"Baiza-Dur\u00e1n","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0845","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jop.2009.0145","article-title":"A comparison of cyclosporine 0.05\u00a0% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial","volume":"26","author":"Chen","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2015.11.008_bib0850","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/ICL.0b013e31822563be","article-title":"Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome","volume":"37","author":"Demiryay","year":"2011","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2015.11.008_bib0855","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/bjophthalmol-2013-304728","article-title":"Topical cyclosporine: are all indications justified?","volume":"98","author":"Aragona","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0860","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05\u00a0% in the treatment of severe dry eye refractory to twice-daily regimen","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0865","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ajo.2008.12.007","article-title":"Occult thyroid eye disease in patients presenting with dry eye symptoms","volume":"147","author":"Gupta","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0870","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2008-1050995","article-title":"Local treatment of corneal transplants in the human with cyclosporin A","volume":"187","author":"Hoffmann","year":"1985","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jfo.2015.11.008_bib0875","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0161-6420(89)32756-4","article-title":"Topical cyclosporine in high-risk corneal transplants","volume":"96","author":"Belin","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0880","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00003226-199309000-00008","article-title":"Topical cyclosporin A in the treatment of anterior segment inflammatory disease","volume":"12","author":"Holland","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0885","first-page":"182","article-title":"Therapeutic use of topical cyclosporine","volume":"25","author":"Kaan","year":"1993","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0890","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0021-5155(99)00223-3","article-title":"Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty","volume":"44","author":"Inoue","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0895","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00417-010-1388-8","article-title":"Efficacy of topical cyclosporine A 2\u00a0% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial","volume":"248","author":"Sinha","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0900","first-page":"627","article-title":"Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty","volume":"28","author":"Xi","year":"2003","journal-title":"Hunan Yi Ke Xue Xue Bao"},{"key":"10.1016\/j.jfo.2015.11.008_bib0905","first-page":"159","article-title":"Topical cyclosporine A in the management of post-keratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5\u00a0% cyclosporine A into the cornea and anterior chamber","volume":"24","author":"Perry","year":"1998","journal-title":"CLAO J"},{"key":"10.1016\/j.jfo.2015.11.008_bib0910","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.ophtha.2006.05.022","article-title":"Efficacy of topical cyclosporine 0.05\u00a0% for prevention of cornea transplant rejection episodes","volume":"113","author":"Price","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0915","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bjo.2008.143024","article-title":"Evaluation of topical ciclosporin 0.05\u00a0% for prevention of rejection in high-risk corneal grafts","volume":"92","author":"Unal","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0920","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.2009.172577","article-title":"Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes","volume":"94","author":"Javadi","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0925","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1442-9071.2008.01784.x","article-title":"Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial","volume":"36","author":"Poon","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0930","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1167\/iovs.02-1323","article-title":"Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis","volume":"44","author":"Fukushima","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0935","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","article-title":"Efficacy of commercially available topical cyclosporine A 0.05\u00a0% in the treatment of meibomian gland dysfunction","volume":"25","author":"Perry","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib0940","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","article-title":"Efficacy of topical cyclosporin 0.05\u00a0% in the treatment of posterior blepharitis","volume":"22","author":"Rubin","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2015.11.008_bib0945","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib0950","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0161-6420(97)30015-3","article-title":"Ocular rosacea: patient characteristics and follow-up","volume":"104","author":"Akpek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0955","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2005.08.035","article-title":"Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis","volume":"141","author":"Doan","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0960","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.jfo.2015.11.008_bib0965","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF02169416","article-title":"Immunopathological study of vernal keratoconjunctivitis","volume":"227","author":"Abu el -Asrar","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0970","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25\u00a0% and 1\u00a0% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0975","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9394(86)90819-6","article-title":"Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis","volume":"101","author":"BenEzra","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0980","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib0985","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0161-6420(91)32154-7","article-title":"Immunopathology of atopic keratoconjunctivitis","volume":"98","author":"Foster","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0990","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0161-6420(98)94017-9","article-title":"Long-term follow-up of patients with atopic keratoconjunctivitis","volume":"105","author":"Power","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib0995","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib1000","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporin 0.05\u00a0% in topical steroid-resistant atopic keratoconjunctivitis","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.11.008_bib1005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib1010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003226-200310001-00004","article-title":"Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation","volume":"22","author":"Ogawa","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib1015","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1167\/iovs.02-0699","article-title":"Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease","volume":"44","author":"Ogawa","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.11.008_bib1020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib1025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"Efficacy of topical cyclosporine 0.05\u00a0% in the treatment of dry eye associated with graft versus host disease","volume":"25","author":"Rao","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib1030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","article-title":"Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease","volume":"41","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jfo.2015.11.008_bib1035","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archopht.120.8.1024","article-title":"Laser-assisted in situ keratomileusis for patients with dry eye","volume":"120","author":"Toda","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib1040","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.jcrs.2004.01.020","article-title":"Survey of complications and recommendations for management in dissatisfied patients seeking a consultation after refractive surgery","volume":"30","author":"Jabbur","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2015.11.008_bib1045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcrs.2003.07.003","article-title":"Chronic dry eye and regression after laser in situ keratomileusis for myopia","volume":"30","author":"Albietz","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2015.11.008_bib1050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3928\/1081-597X-20010101-02","article-title":"Corneal sensitivity and some properties of the tear film after laser in situ keratomileusis","volume":"17","author":"Patel","year":"2001","journal-title":"J Refract Surg"},{"key":"10.1016\/j.jfo.2015.11.008_bib1055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib1060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0002-9394(98)00444-9","article-title":"Corneal sensitivity after photorefractive keratectomy and laser in situ keratomileusis for low myopia","volume":"127","author":"P\u00e9rez-Santonja","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib1065","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajo.2005.07.027","article-title":"Recovery of corneal subbasal nerve density after PRK and LASIK","volume":"140","author":"Erie","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib1070","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajo.2005.11.042","article-title":"Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1\u00a0% with topical cyclosporine 0.05\u00a0%","volume":"141","author":"Rao","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.11.008_bib1075","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/ICO.0b013e31820cd607","article-title":"Cyclosporine A 1\u00a0% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis","volume":"30","author":"Jeng","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib1080","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/ICO.0b013e3181c33034","article-title":"Topical treatment with 1\u00a0% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis","volume":"29","author":"Levinger","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.11.008_bib1085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.icl.0000175651.30487.58","article-title":"Use of cyclosporine 0.05\u00a0% ophthalmic emulsion for contact lens-intolerant patients","volume":"32","author":"Hom","year":"2006","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jfo.2015.11.008_bib1090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/10807680260362696","article-title":"Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease","volume":"18","author":"Small","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfo.2015.11.008_bib1095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.iio.0000212135.77675.6a","article-title":"Topical cyclosporine for treatment of ocular surface disease","volume":"46","author":"Foulks","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.jfo.2015.11.008_bib1100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199907293410516","article-title":"Carcinoma of the corneoscleral limbus in a patient treated with cyclosporine after heart transplantation","volume":"341","author":"Touzeau","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551216000619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551216000619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:06:29Z","timestamp":1759259189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551216000619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0181551216000619"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2015.11.008","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La ciclosporine\u00a0topique en ophtalmologie\u00a0: pharmacologie et indications th\u00e9rapeutiques","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2015.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}